Antibodies | Top 10 Cited Papers in 2023

1. “A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19)”
by Kristin Widyasari and Jinnam Kim
Antibodies 2023, 12(1), 5; https://doi.org/10.3390/antib12010005
Available online: https://www.mdpi.com/2073-4468/12/1/5

2. “Non-Affinity Purification of Antibodies”
by Tsutomu Arakawa, Yui Tomioka, Masataka Nakagawa, Chiaki Sakuma, Yasunori Kurosawa, Daisuke Ejima, Kouhei Tsumoto and Teruo Akuta
Antibodies 2023, 12(1), 15; https://doi.org/10.3390/antib12010015
Available online: https://www.mdpi.com/2073-4468/12/1/15

3. “Serological Cross-Reactivity in Zoonotic Flaviviral Infections of Medical Importance”
by Priscilla Gomes da Silva, José Augusto Seixas dos Reis, Marcio Nogueira Rodrigues, Quézia da Silva Ardaya and João Rodrigo Mesquita
Antibodies 2023, 12(1), 18; https://doi.org/10.3390/antib12010018
Available online: https://www.mdpi.com/2073-4468/12/1/18

4. “Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation”
by Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry and Suprabhat Mukherjee
Antibodies 2023, 12(1), 17; https://doi.org/10.3390/antib12010017
Available online: https://www.mdpi.com/2073-4468/12/1/17

5. “Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine”
by Tsvetelina Velikova, Metodija Sekulovski, Simona Bogdanova, Georgi Vasilev, Monika Peshevska-Sekulovska, Dimitrina Miteva and Tsvetoslav Georgiev
Antibodies 2023, 12(1), 20; https://doi.org/10.3390/antib12010020
Available online: https://www.mdpi.com/2073-4468/12/1/20

6. “The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review”
by Razwana Khanam, Omer S. Ashruf, Syed Hamza Bin Waqar, Zunairah Shah, Saba Batool, Rameesha Mehreen, Pranali Pachika, Zinath Roksana, Mohammad Ebad Ur Rehman and Faiz Answer
Antibodies 2023, 12(2), 38; https://doi.org/10.3390/antib12020038
Available online: https://www.mdpi.com/2073-4468/12/2/38

7. “Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update”
by Elvis Hysa, Rosanna Campitiello, Silvia Sammorì, Emanuele Gotelli, Andrea Cere, Giampaola Pesce, Carmen Pizzorni, Sabrina Paolino, Alberto Sulli, Vanessa Smith et al.
Antibodies 2023, 12(1), 3; https://doi.org/10.3390/antib12010003
Available online: http://www.mdpi.com/2073-4468/12/1/3

8. “New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond”
by Marino Paroli, Chiara Gioia and Daniele Accapezzato
Antibodies 2023, 12(1), 25; https://doi.org/10.3390/antib12010025
Available online: http://www.mdpi.com/2073-4468/12/1/25

9. “CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases”
by Sara Gómez-Melero and Javier Caballero-Villarraso
Antibodies 2023, 12(2), 30; https://doi.org/10.3390/antib12020030
Available online: https://www.mdpi.com/2073-4468/12/2/30

10. “Bioprocess Development and Characterization of a ¹³C-Labeled Hybrid Bispecific Antibody Produced in Escherichia coli”
by Aaron T. Wecksler, Victor Lundin, Ambrose J. Williams, Karthik Veeravalli, Dorothea E. Reilly and Sung-Hye Grieco
Antibodies 2023, 12(1), 16; https://doi.org/10.3390/antib12010016
Available online: https://www.mdpi.com/2073-4468/12/1/16#